Intero Biosystems wants drugmakers to test on mini human intestines, not animals

A tech story from the U.S., reported by TechCrunch.

Tech · the U.S. · October 14, 2026

From TechCrunch

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

Reported by TechCrunch, October 14, 2026. Read the full story at TechCrunch →

More tech from the U.S.

How AI is helping criminals launch ransomware attacks · CBS News
Palo Alto Networks warns of PAN-OS RCE flaw exploited in attacks · BleepingComputer
AI now linked to 84% of ransomware attacks, report finds · CBS News
Fridge hack costing millions and sparking fires stemmed from poor security · Ars Technica
Epic says its new vibe-coded Epic Games Launcher is faster than Steam · Ars Technica
NATO may redeploy anti-drone defenses as attacks sink more Black Sea shipping · Ars Technica
Trump Aides Admit the House Is a Lost Cause · Wired
Things are finally looking up for NASA's first missions to Venus in a generation · Ars Technica

All tech → · the U.S. local news →

Open HeyHomees →